Celecoxib Versus Omeprazole and Diclofenac in Patients With Osteoarthritis and Rheumatoid Arthritis - CONDOR


The goal of the trial was to evaluate treatment with celecoxib, a cyclooxygenase (COX)-2 selective nonsteroidal anti-inflammatory drug (NSAID), versus diclofenac plus omeprazole in patients with osteoarthritis or rheumatoid arthritis.

Diclofenac is considered a nonselective NSAID, although it is relatively selective against the COX-2 isoenzyme.